logo
Select company
Select metric
$ -35.97MEarning Before Interest & Taxes (EBIT)
VS
Market
19
Sector
43
Industry
56
History
71
$ 9.65Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -35.97M
3/31/2025$ -38.02M
12/31/2024$ -77.14M
9/30/2024$ -263.83M
6/30/2024$ -247.38M
3/31/2024$ -271.85M
12/31/2023$ -235.88M
9/30/2023$ -32.81M
6/30/2023$ -32.49M
3/31/2023$ -12.54M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -67.14M.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average EBIT has been $ -67.96M.
  • The median EBIT for CARTESIAN THERAPEUTICS INC during this period was $ -37M
  • CARTESIAN THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ 50.53M.
  • The lowest EBIT recorded by CARTESIAN THERAPEUTICS INC in the same timeframe $ -271.85M

CARTESIAN THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
HUMA : HUMACYTE INC $ -48.17MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ -74.32MMREO : MEREO BIOPHARMA GROUP PLC $ -50.35MINBX : INHIBRX BIOSCIENCES INC $ -157.86MCRDF : CARDIFF ONCOLOGY INC $ -51.02MBTAI : BIOXCEL THERAPEUTICS INC $ -34.91MCATX : PERSPECTIVE THERAPEUTICS INC $ -96.81MADVM : ADVERUM BIOTECHNOLOGIES INC $ -183.87MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.4MLSTA : LISATA THERAPEUTICS INC $ -19.89M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

RNAC - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -271.85M

Minimum

Mar 31, 2024

$ 50.53M

Maximum

Jun 30, 2022

$ -67.96M

Average

$ -37M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.48M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442M
average$ 28.48M
median$ 847.86K
std$ 130.48M